IFLR1000

Unilabs SubHolding €250 million 5.75% notes issue

5/5/2017
High-yield bond/note issue
Select tab

€ 250 million

$ 273 million

Completed

5/5/2017

Overview:

  • Unilabs SubHolding has offered €250 million in new senior notes. 
  • The 5.75% notes are due in 2025.
  • Unilabs SubHolding used the proceeds from this issue to part finance the acquisition of Alpha Medical and repay €125 million in Pik toggle notes due 2022 issued by Unilabs MidHolding.
  • The notes will be offered only to qualified institutional buyers pursuant to Rule 144A/Reg S.
  • Credit Suisse, Deutsche Bank, HSBC, BNP Paribas, JPMorgan and UniCredit acted as initial purchasers.
  • Unilabs SubHolding is a wholly owned subsidiary of Unilabs Holding (Unilabs), an Apax portfolio company.
  • Unilabs is one of Europe’s leading suppliers of clinical laboratory testing and medical diagnostic imaging services.

Katrin Kostadinova - Deal analyst

Jurisdiction:

United Kingdom

Deal type:

High-yield bond/note issue

Practice area:

Capital markets : Debt

Governing law:

England and Wales

Industry sectors:

Healthcare
Pharmaceuticals and life sciences

Firms:
Linklaters

Party: Credit Suisse (Initial purchaser)

Party: Deutsche Bank (Initial purchaser)

Party: HSBC (Initial purchaser)

Party: BNP Paribas (Initial purchaser)

Party: Unicredit (Initial purchaser)

Party: JPMorgan (Initial purchaser)

Lawyers: Mark Hageman, Nick Syson

Simpson Thacher & Bartlett

Party: Unilabs SubHolding AB (Issuer)

Lawyers: Kate Sinclair, Nicholas Shaw

Related deals